HB 870·LA·house
INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
Signed into LawFiled Feb 27, 2026
Sponsor: Chris Turner (R)
Latest Action
Signed by the Governor. Becomes Act No. 907.
Jun 12, 2026
Topics
Track this bill
Get real-time alerts when HB 870 changes status, plus AI-powered summaries and stage predictions.
Sign up free